APA

Li W., Jia X., Shen C., Zhang M., Xu J., Shang Y., Zhu K., Hu M., Yan Q., Qin D., Lee M., Zhu J., Lu H., Krueger B. J., Renne R., Gao S. & Lu C. (20171226). A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathway. : Oncotarget.

Chicago

Li Wan, Jia Xuemei, Shen Chenyou, Zhang Mi, Xu Jingyun, Shang Yuancui, Zhu Kaixiang, Hu Minmin, Yan Qin, Qin Di, Lee Myung-Shin, Zhu Jianzhong, Lu Hongmei, Krueger Brian J, Renne Rolf, Gao Shou-Jiang and Lu Chun. 20171226. A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathway. : Oncotarget.

Harvard

Li W., Jia X., Shen C., Zhang M., Xu J., Shang Y., Zhu K., Hu M., Yan Q., Qin D., Lee M., Zhu J., Lu H., Krueger B. J., Renne R., Gao S. and Lu C. (20171226). A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathway. : Oncotarget.

MLA

Li Wan, Jia Xuemei, Shen Chenyou, Zhang Mi, Xu Jingyun, Shang Yuancui, Zhu Kaixiang, Hu Minmin, Yan Qin, Qin Di, Lee Myung-Shin, Zhu Jianzhong, Lu Hongmei, Krueger Brian J, Renne Rolf, Gao Shou-Jiang and Lu Chun. A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathway. : Oncotarget. 20171226.